FDA Sounds Alarm Over J&J Antifungal Drug Nizoral

Law360, New York (July 26, 2013, 5:28 PM EDT) -- The U.S. Food and Drug Administration on Friday unveiled extensive warnings about Johnson & Johnson’s antifungal treatment Nizoral, saying serious liver and kidney damage could result from even short-term use of the medicine’s oral form.

A J&J spokeswoman said the product hasn’t been produced for the U.S. since 2005 and that the company is in the process of having it formally withdrawn from the American market. In the meantime, the drugmaker will fulfill its obligations to update Nizoral’s label to reflect new warnings, the spokeswoman said....
To view the full article, register now.